December, 2018 (2)

• Effectiveness of repellent delivered through village health volunteers on malaria incidence in villages in South-East Myanmar: a stepped-wedge cluster-randomised controlled trial protocol.
  Win Han Oo, Cutts JC, Agius PA, Kyaw Zayar Aung, Poe Poe Aung, Aung Thi, Nyi Nyi Zaw, Htin Kyaw Thu, Wai Yan Min Htay, Ataide R, O'Flaherty K, Ai Pao Yawn, Aung Paing Soe, Beeson JG, Crabb B, Pasricha N, Fowkes FJI
  BMC Infect Dis. 2018 Dec; 18(1):663
• Detectable Plasma HIV RNA Is Associated With Sensory Neuropathy in Patients With HIV Treated Without Stavudine.
  Octaviana F, Safri AY, Setiawan DD, Estiasari R, Imran D, Ranakusuma T, Affandi J, Cherry CL, Price P
  J Acquir Immune Defic Syndr. 2018 Dec; 79(4):e108-e110

November, 2018 (1)

• Monitoring the Control of Sexually Transmissible Infections and Blood-Borne Viruses: Protocol for the Australian Collaboration for Coordinated Enhanced Sentinel Surveillance (ACCESS).
  Callander D, Moreira C, El-Hayek C, Asselin J, van Gemert C, Watchirs Smith L, Nguyen L, Dimech W, Boyle DI, Donovan B, Stoové M, Hellard M, Guy R
  JMIR Res Protoc. 2018 Nov; 7(11):e11028

October, 2018 (10)

• Paritaprevir, ritonavir, ombitasvir, and dasabuvir with and without ribavirin in people with HCV genotype 1 and recent injecting drug use or receiving opioid substitution therapy.
  Grebely J, Conway B, Cunningham EB, Fraser C, Moriggia A, Gane E, Stedman C, Cooper C, Castro E, Schmid P, Petoumenos K, Hajarizadeh B, Marks P, Erratt A, Dalgard O, Lacombe K, Feld JJ, Bruneau J, Daulouede JP, Powis J, Bruggmann P, Matthews GV, Kronborg I, Shaw D, Dunlop A, Hellard M, Applegate TL, Crawford S, Dore GJ; D3FEAT Study Group
  Int J Drug Policy. 2018 Oct; 62:94-103
• Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis.
  Stone J, Fraser H, Lim AG, Walker JG, Ward Z, MacGregor L, Trickey A, Abbott S, Strathdee SA, Abramovitz D, Maher L, Iversen J, Bruneau J, Zang G, Garfein RS, Yen YF, Azim T, Mehta SH, Milloy MJ, Hellard ME, Sacks-Davis R, Dietze PM, Aitken C, Aladashvili M, Tsertsvadze T, Mravčík V, Alary M, Roy E, Smyrnov P, Sazonova Y, Young AM, Havens JR, Hope VD, Desai M, Heinsbroek E, Hutchinson SJ, Palmateer NE, McAuley A, Platt L, Martin NK, Altice FL, Hickman M, Vickerman P
  Lancet Infect Dis. 2018 Oct; 18(12):1397-1409
• Assessing the operational feasibility and acceptability of an inhalable formulation of oxytocin for improving community-based prevention of postpartum haemorrhage in Myanmar: a qualitative inquiry.
  Than KK, Oliver V, Mohamed Y, La T, Lambert P, McIntosh M, Luchters S
  BMJ Open. 2018 Oct; 8(10):e022140
• Adherence to sofosbuvir and velpatasvir among people with chronic HCV infection and recent injection drug use: The SIMPLIFY study.
  Cunningham EB, Amin J, Feld JJ, Bruneau J, Dalgard O, Powis J, Hellard M, Cooper C, Read P, Conway B, Dunlop AJ, Norton B, Litwin AH, Hajarizadeh B, Thurnheer MC, Dillon JF, Weltman M, Shaw D, Bruggmann P, Gane E, Fraser C, Marks P, Applegate TL, Quiene S, Siriragavan S, Matthews GV, Dore GJ, Grebely J; SIMPLIFY study group
  Int J Drug Policy. 2018 Oct; 62:14-23
• Lifetime prevalence and correlates of self-harm and suicide attempts among male prisoners with histories of injecting drug use.
  Stewart AC, Cossar R, Dietze P, Armstrong G, Curtis M, Kinner SA, Ogloff JRP, Kirwan A, Stoové M
  Health Justice. 2018 Oct; 6(1):19
• Aiming for 90-90-90 - the importance of understanding the risk factors for HIV exposure and advanced HIV infection in migrant populations and other groups who do not report male-to-male sex.
  Peach E, Lemoh C, Stoové M, Agius P, El Hayek C, Higgins N, Hellard M
  Sex Health. 2018 Oct; 15(5):441-450
• Blood-borne virus transmission in an urban, culturally diverse neighbourhood: results from a cross-sectional bio-behavioural survey using innovative outreach methods in a hard-to-reach population.
  Peach E, Cogger S, Byron K, Francis P, O'Keefe D, Higgs P, Stoove M, Elmore K, Dietze P, Hellard M
  Sex Health. 2018 Oct; 15(1):54-60
• Pathways to ensure universal and affordable access to hepatitis C treatment.
  Douglass CH, Pedrana A, Lazarus JV, 't Hoen EFM, Hammad R, Leite RB, Hill A, Hellard M
  BMC Med. 2018 Oct; 16(1):175
• Menstrual hygiene management and school absenteeism among adolescent students in Indonesia: evidence from a cross-sectional school-based survey.
  Davis J, Macintyre A, Odagiri M, Suriastini W, Cordova A, Huggett C, Agius PA, Faiqoh, Budiyani AE, Quillet C, Cronin AA, Diah M, Triwahyunto A, Luchters S, Kennedy E
  Trop Med Int Health. 2018 Oct; 23(12):1350-1363
• "Optima attempts to objectively and pragmatically assist countries meet their targets most efficiently and effectively".
  Wilson DP, Gorgens M, Wilson DJ; Optima HIV study team (including: Robyn M Stuart, Cliff C Kerr, Jolene Skordis, Olivia Keiser, Sherrie Kelly, Rowan Martin-Hughes, Janka Petravic, Richard Gray and Nejma Cheikh)
  J Int AIDS Soc. 2018 Oct; 21(10):e25190

September, 2018 (4)

• Dimeric FcgammaR ectodomains detect pathogenic platelet factor 4-heparin antibodies in heparin induced thromobocytopenia.
  Wines BD, Tan CW, Duncan E, McRae S, Baker RI, Andrews RK, Esparon S, Gardiner EE, Hogarth PM
  J Thromb Haemost. 2018 Sep; 16(12):2520–2525
• Knowledge, perception and practice towards oxytocin stability and quality: A qualitative study of stakeholders in three resource-limited countries.
  Oliver VL, Lambert PA, Than KK, Mohamed Y, Luchters S, Verma S, Yadav R, Kumar V, Teklu AM, Tolera M, Minaye A, McIntosh MP
  PLoS One. 2018 Sep; 13(9):e0203810
• Incidence of unintended pregnancy among female sex workers in low-income and middle-income countries: a systematic review and meta-analysis.
  Ampt FH, Willenberg L, Agius PA, Chersich M, Luchters S, Lim MSC
  BMJ Open. 2018 Sep; 8(9):e021779
• Induction of HIF-1alpha by HIV-1 Infection in CD4(+) T Cells Promotes Viral Replication and Drives Extracellular Vesicle-Mediated Inflammation.
  Duette G, Pereyra Gerber P, Rubione J, Perez PS, Landay AL, Crowe SM, Liao Z, Witwer KW, Holgado MP, Salido J, Geffner J, Sued O, Palmer CS, Ostrowski M
  MBio. 2018 Sep; 9(5)

August, 2018 (5)

• Analysis of time of drug use according to needle and syringe program operating hours in Melbourne, Australia: Effects on individual-level needle and syringe coverage.
  O'Keefe D, Aitken C, Scott N, Dietze P
  Drug Alcohol Depend. 2018 Aug; 191:259-265
• The Rare Anaphylaxis-Associated FcgammaRIIa3 Exhibits Distinct Characteristics From the Canonical FcgammaRIIa1.
  Anania JC, Trist HM, Palmer CS, Tan PS, Kouskousis BP, Chenoweth AM, Kent SJ, Mackay GA, Hoi A, Koelmeyer R, Slade C, Bryant VL, Hodgkin PD, Aui PM, van Zelm MC, Wines BD, Hogarth PM
  Front Immunol. 2018 Aug; 9:1809
• Achieving a hepatitis C cure: a qualitative exploration of the experiences and meanings of achieving a hepatitis C cure using the direct acting antivirals in Australia.
  Richmond JA, Ellard J, Wallace J, Thorpe R, Higgs P, Hellard M, Thompson A
  Hepatol Med Policy. 2018 Aug; 3:8
• Implications of population-level immunity for the emergence of artemisinin-resistant malaria: a mathematical model.
  Scott N, Ataide R, Wilson DP, Hellard M, Price RN, Simpson JA, Fowkes FJI
  Malar J. 2018 Aug; 17(1):279
• Evolutionary study and phylodynamic pattern of human influenza A/H3N2 virus in Indonesia from 2008 to 2010.
  Agustiningsih A, Trimarsanto H, Restuadi R, Artika IM, Hellard M, Muljono DH
  PLoS One. 2018 Aug; 13(8):e0201427

July, 2018 (11)

• Safe sex in chick lit: a ‘novel’ analysis of sexual health references in popular women’s fiction.
  Lim MSC, Hellard ME, Horyniak
  Sex Health. 2018 Jul; 15(5):468-472
• Eliminating hepatitis C: the importance of frequent testing of people who inject drugs in high prevalence settings.
  Scott N, Sacks-Davis R, Pedrana A, Doyle J, Thompson A, Hellard M
  J Viral Hepat. 2018 Jul; 25(12):1472-1480
• Mobile Phone-Based Ecological Momentary Intervention to Reduce Young Adults' Alcohol Use in the Event: A Three-Armed Randomized Controlled Trial.
  Wright C, Dietze PM, Agius PA, Kuntsche E, Livingston M, Black OC, Room R, Hellard M, Lim MS
  JMIR Mhealth Uhealth. 2018 Jul; 6(7):e149
• Determining the effective dose of street-level heroin: A new way to consider fluctuations in heroin purity, mass and potential contribution to overdose.
  Stam NC, Gerostamoulos D, Gerstner-Stevens J, Scott N, Smith K, Drummer OH, Pilgrim JL
  Forensic Sci Int. 2018 Jul; 290:219-226
• Addressing multiple modifiable risks through structured community-based Learning Clubs to improve maternal and infant health and infant development in rural Vietnam: protocol for a parallel group cluster randomised controlled trial.
  Fisher J, Tran T, Luchters S, Tran TD, Hipgrave DB, Hanieh S, Tran H, Simpson J, Nguyen T, Le M, Biggs BA
  BMJ Open. 2018 Jul; 8(7):e023539
• Community-based provision of direct-acting antiviral therapy for hepatitis C: study protocol and challenges of a randomized controlled trial.
  Wade AJ, Doyle JS, Gane E, Stedman C, Draper B, Iser D, Roberts SK, Kemp W, Petrie D, Scott N, Higgs P, Agius PA, Roney J, Stothers L, Thompson AJ, Hellard ME
  Trials. 2018 Jul; 19(1):383
• Anti-HIV-1 Activity of Lactic Acid in Human Cervicovaginal Fluid.
  Tyssen D, Wang YY, Hayward JA, Agius PA, DeLong K, Aldunate M, Ravel J, Moench TR, Cone RA, Tachedjian G
  mSphere. 2018 Jul; 3(4):e00055-18
• Direct Anterior Approach Total Hip Arthroplasty: An Adjunct to an Enhanced Recovery Pathway: Outcomes and Learning Curve Effects in Surgeons Transitioning From Other Surgical Approaches.
  Free MD, Owen DH, Agius PA, Pascoe EM, Harvie P
  J Arthroplasty. 2018 Jul; 33(11):3490-3495
• Cost and cost-effectiveness analysis of pre-exposure prophylaxis among men who have sex with men in two hospitals in Thailand.
  Suraratdecha C, Stuart RM, Manopaiboon C, Green D, Lertpiriyasuwat C, Wilson DP, Pavaputanon P, Visavakum P, Monkongdee P, Khawcharoenporn T, Tharee P, Kittinunvorakoon C, Martin M
  J Int AIDS Soc. 2018 Jul; 21 Suppl 5:e25129
• Report from the International Viral Hepatitis Elimination Meeting (IVHEM), 17-18 November 2017, Amsterdam, the Netherlands: gaps and challenges in the WHO 2030 hepatitis C elimination framework.
  Popping S, El-Sayed M, Feld J, Hatzakis A, Hellard M, Lesi O, Ninburg M, Ward J, Boucher C
  J Virus Erad. 2018 Jul; 4(3):193-195
• Suppression of monocyte inflammatory and coagulopathy responses in HIV infection.
  Rajasuriar R, Hearps AC, Crowe SM, Anzinger JJ, Palmer CS
  Ann Transl Med. 2018 Jul; 6(13):277

June, 2018 (4)

• Hepatitis C virus notification rates in Australia are highest in socioeconomically disadvantaged areas.
  Hainsworth SW, Dietze PM, Wilson DP, Sutton B, Hellard ME, Scott N
  PLoS One. 2018 Jun; 13(6):e0198336
• Repeat participation in annual cross-sectional surveys of drug users and its implications for analysis.
  Agius PA, Aitken CK, Breen C, Dietze PM
  BMC Res Notes. 2018 Jun; 11(1):349
• Measuring and understanding the attitudes of Australian gay and bisexual men towards biomedical HIV prevention using cross-sectional data and factor analyses.
  Wilkinson AL, Draper BL, Pedrana AE, Asselin J, Holt M, Hellard ME, Stoové M
  Sex Transm Infect. 2018 Jun; 94(4):309-3014
• Cost-effectiveness of the controlled temperature chain for the hepatitis B virus birth dose vaccine in various global settings: a modelling study.
  Scott N, Palmer A, Morgan C, Lesi O, Spearman CW, Sonderup M, Hellard M
  Lancet Glob Health. 2018 Jun; 6(6):e659-e667

May, 2018 (8)

• Anti-influenza Hyperimmune Immunoglobulin Enhances Fc-functional Antibody Immunity during Human Influenza Infection.
  Vanderven HA, Wragg K, Ana-Sosa-Batiz F, Kristensen AB, Jegaskanda S, Wheatley AK, Wentworth D, Wines BD, Hogarth PM, Rockman S; INSIGHT FLU005 Pilot Study Writing Group, Kent SJ
  J Infect Dis. 2018 May; 218(9):1383-1393
• Protocol for an HIV Pre-exposure Prophylaxis (PrEP) Population Level Intervention Study in Victoria Australia: The PrEPX Study.
  Ryan KE, Mak A, Stoove M, Price B, Fairley CK, Ruth S, Lal L, Asselin J, El-Hayek C, Nguyen L, Batrouney C, Wilson D, Lockwood J, Murphy D, Cornelisse VJ, Roth N, Willcox J, Chang CC, Armishaw J, Tee BK, Penn M, Forgan-Smith G, Williams C, Montgomery J, Byron K, Coelho A, Allen B, Wiggins J, Kelsall J, Vujovic O, West M, Pierce AB, Gallant D, Bell C, de Wit JBF, Hoy JF, Wesselingh SL, Grant RM, Wright EJ
  Front Public Health. 2018 May; 6:151
• Polymorphism rs1385129 Within Glut1 Gene SLC2A1 Is Linked to Poor CD4+ T Cell Recovery in Antiretroviral-Treated HIV+ Individuals.
  Masson JJR, Cherry CL, Murphy NM, Sada-Ovalle I, Hussain T, Palchaudhuri R, Martinson J, Landay AL, Billah B, Crowe SM, Palmer CS
  Front Immunol. 2018 May; 9:900
• Factors associated with social participation amongst elders in rural Sri Lanka: a cross-sectional mixed methods analysis.
  Marsh C, Agius PA, Jayakody G, Shajehan R, Abeywickrema C, Durrant K, Luchters S, Holmes W
  BMC Public Health. 2018 May; 18(1):636
• Molecular test for chlamydia and gonorrhoea used at point of care in remote primary healthcare settings: a diagnostic test evaluation.
  Causer LM, Guy RJ, Tabrizi SN, Whiley DM, Speers DJ, Ward J, Tangey A, Badman SG, Hengel B, Natoli LJ, Anderson DA, Wand H, Wilson D, Regan DG, Shephard M, Donovan B, Fairley CK, Kaldor JM
  Sex Transm Infect. 2018 May; 94(5):340-345
• Expectant fathers' participation in antenatal care services in Papua New Guinea: a qualitative inquiry.
  Davis J, Vaughan C, Nankinga J, Davidson L, Kigodi H, Alalo E, Comrie-Thomson L, Luchters S
  BMC Pregnancy Childbirth. 2018 May; 18(1):138
• Eliminating HIV/HCV co-infection in gay and bisexual men: is it achievable through scaling up treatment?
  Sacks-Davis R, Pedrana AE, Scott N, Doyle JS, Hellard ME
  Expert Rev Anti Infect Ther. 2018 May; 16(5):411-422
• Implications of survey labels and categorisations for understanding drug use in the context of sex among gay and bisexual men in Melbourne, Australia.
  Ryan KE, Wilkinson AL, Pedrana A, Quinn B, Dietze P, Hellard M, Stoové M
  Int J Drug Policy. 2018 May; 55:183-186

April, 2018 (9)

• The effect of monitoring viral load and tracing patients lost to follow-up on the course of the HIV epidemic in Malawi: A mathematical model.
  Estill J, Kerr CC, Blaser N, Salazar-Vizcaya L, Tenthani L, Wilson, DP, Keiser, O
  Open Forum Infectious Diseases. 2018 Apr; 5(5):ofy092
• Aiming for elimination: outcomes of a consultation pathway supporting regional general practitioners to prescribe direct acting antiviral therapy for hepatitis C.
  Wade AJ, McCormack A, Roder C, McDonald K, Davies M, Scott N, Wardrop M, Athan E, Hellard ME
  J Viral Hepat. 2018 Apr; 25(9):1089-1098
• Experiences of liver health related uncertainty and self-reported stress among people who inject drugs living with hepatitis C virus: a qualitative study.
  Goutzamanis S, Doyle JS, Thompson A, Dietze P, Hellard M, Higgs P; TAP study group.
  BMC Infect Dis. 2018 Apr; 18(1):151
• Which attributes within target product profiles for tuberculosis diagnostics are the most important to focus on?
  Adepoyibi T, Lilis L, Greb H, Boyle D
  Int J Tuberc Lung Dis. 2018 Apr; 22(4):425-428
• Undiagnosed HIV infections among gay and bisexual men increasingly contribute to new infections in Australia.
  Gray RT, Wilson DP, Guy RJ, Stoové M, Hellard ME, Prestage GP, Lea T, de Wit J, Holt M
  J Int AIDS Soc. 2018 Apr; 21(4):e25104
• Linkage and retention in HCV care for HIV-infected populations: early data from the DAA era.
  Sacks-Davis R, Doyle JS, Rauch A, Beguelin C, Pedrana AE, Matthews GV, Prins M, van der Valk M, Klein MB, Saeed S, Lacombe K, Chkhartishvili N, Altice FL, Hellard ME
  J Int AIDS Soc. 2018 Apr; 21 Suppl 2:e25051
• How should HIV resources be allocated? Lessons learnt from applying Optima HIV in 23 countries.
  Stuart RM, Grobicki L, Haghparast-Bidgoli H, Panovska-Griffiths J, Skordis J, Keiser O, Estill J, Baranczuk Z, Kelly SL, Reporter I, Kedziora DJ, Shattock AJ, Petravic J, Hussain SA, Grantham KL, Gray RT, Yap XF, Martin-Hughes R, Benedikt CJ, Fraser-Hurt N, Masaki E, Wilson DJ, Gorgens M, Mziray E, Cheikh N, Shubber Z, Kerr CC, Wilson DP
  J Int AIDS Soc. 2018 Apr; 21(4):e25097
• The 2016 HIV diagnosis and care cascade in New South Wales, Australia: meeting the UNAIDS 90-90-90 targets.
  Keen P, Gray RT, Telfer B, Guy R, Schmidt HM, Whittaker B, Holden J, Holt M, Kelleher A, Wilson D, Callander D, Cooper DA, Prestage G, Selvey C, Grulich AE; NSW HIV Prevention Partnership Project.
  J Int AIDS Soc. 2018 Apr; 21(4):e25109
• Heterogeneity in hepatitis C treatment prescribing and uptake in Australia: a geospatial analysis of a year of unrestricted treatment access.
  Scott N, Hainsworth SW, Sacks-Davis R, Pedrana A, Doyle J, Wade A, Hellard M
  J Virus Erad. 2018 Apr; 4(2):108-114

March, 2018 (10)

• Human papilloma virus correlates of high grade cervical dysplasia in HIV-infected women in Mombasa, Kenya: a cross-sectional analysis.
  Menon S, Luchters S, Rossi R, Callens S, Kishor M, Bogers J, Vanden Broeck D
  Virol J. 2018 Mar; 15(1):54
• Optima Nutrition: an allocative efficiency tool to reduce childhood stunting by better targeting of nutrition-related interventions.
  Pearson R, Killedar M, Petravic J, Kakietek JJ, Scott N, Grantham KL, Stuart RM, Kedziora DJ, Kerr CC, Skordis-Worrall J, Shekhar M, Wilson DP
  BMC Public Health. 2018 Mar; 18(1):384
• Loss of NF-kappaB1 Causes Gastric Cancer with Aberrant Inflammation and Expression of Immune Checkpoint Regulators in a STAT-1-Dependent Manner.
  O'Reilly LA, Putoczki TL, Mielke LA, Low JT, Lin A, Preaudet A, Herold MJ, Yaprianto K, Tai L, Kueh A, Pacini G, Ferrero RL, Gugasyan R, Hu Y, Christie M, Wilcox S, Grumont R, Griffin MDW, O'Connor L, Smyth GK, Ernst M, Waring P, Gerondakis S, Strasser A
  Immunity. 2018 Mar; 48(3):570-583
• Achieving 90-90-90 HIV targets will not be enough to achieve the HIV incidence reduction target in Australia.
  Scott N, Stoové M, Kelly SL, Wilson DP, Hellard ME
  Clin Infect Dis. 2018 Mar; 66(7):1019-1023
• Optimization by Adaptive Stochastic Descent.
  Kerr CC, Dura-Bernal S, Smolinski TG, Chadderdon GL, Wilson DP
  PLoS One. 2018 Mar; 13(3):e0192944
• The global Optima HIV allocative efficiency model: targeting resources in efforts to end AIDS.
  Kelly SL, Martin-Hughes R, Stuart RM, Yap XF, Kedziora DJ, Grantham KL, Hussain SA, Reporter I, Shattock AJ, Grobicki L, Haghparast-Bidgoli H, Skordis-Worrall J, Baranczuk Z, Keiser O, Estill J, Petravic J, Gray RT, Benedikt CJ, Fraser N, Gorgens M, Wilson D, Kerr CC, Wilson DP
  Lancet HIV. 2018 Mar; 5(4):e190-e198
• Comparing Australian gay and bisexual men with undiagnosed and recently diagnosed HIV infection to those in the National HIV Registry.
  Down I, Prestage G, Brown G, Ellard J, Guy R, Hellard M, Wilson D, de Wit J, Stoové M, Holt M
  Sex Health. 2018 Mar; 15(3):276-281
• Effects of Pre-exposure Prophylaxis for the Prevention of HIV Infection on Sexual Risk Behavior in Men Who Have Sex with Men: A Systematic Review and Meta-analysis.
  Traeger MW, Schroeder SE, Wright EJ, Hellard ME, Cornelisse VJ, Doyle JS, Stoové MA
  Clin Infect Dis. 2018 Mar; 67(5):676-686
• Rising Chlamydia and Gonorrhoea Incidence and Associated Risk Factors Among Female Sex Workers in Australia: A Retrospective Cohort Study.
  Callander D, McManus H, Guy R, Hellard M, O'Connor CC, Fairley CK, Chow EPF, McNulty A, Lewis DA, Carmody C, Schmidt HA, Kim J, Donovan B
  Sex Transm Dis. 2018 Mar; 45(3):199-206
• Producing an evidence-based treatment information website in partnership with people affected by multiple sclerosis.
  Synnot AJ, Hawkins M, Merner BA, Summers MP, Filippini G, Osborne RH, Shapland SDP, Cherry CL, Stuckey R, Milne CA, Mosconi P, Colombo C, Hill SJ
  Health Sci Rep. 2018 Mar; 1(3):e24

February, 2018 (11)

• Escape of Hepatitis C virus from epitope I neutralization increases sensitivity of other neutralization epitopes.
  Gu J, Hardy J, Boo I, Vietheer P, McCaffrey K, Alhammad Y, Chopra A, Gaudieri S, Poumbourios P, Coulibaly F, Drummer HE
  J Virol. 2018 Feb; 92(9):e02066-17
• Risk of unplanned caesarean birth in Vietnamese-born women in Victoria, Australia: A cross-sectional study.
  Agius PA, Davey MA, Small R
  Women Birth. 2018 Feb; 31(6):496-504
• Establishment of a yeast-based VLP platform for antigen presentation.
  Wetzel D, Rolf T, Suckow M, Kranz A, Barbian A, Chan JA, Leitsch J, Weniger M, Jenzelewski V, Kouskousis B, Palmer C, Beeson JG, Schembecker G, Merz J, Piontek M
  Microb Cell Fact. 2018 Feb; 17(1):17
• Higher transplacental pathogen-specific antibody transfer among pregnant women randomized to triple antiretroviral treatment versus short course zidovudine.
  Bosire R, Farquhar C, Nduati R, Broliden K, Luchters S, Van de Perre P, De Vincenzi I, Merkel M, Wachuka V, Mbori-Ngacha D, John-Stewart G, Lohman-Payne B, Reilly M
  Pediatr Infect Dis J. 2018 Feb; 37(3):246-252
• Perturbed CD8+ T cell immunity across universal influenza epitopes in the elderly.
  Nguyen THO, Sant S, Bird NL, Grant EJ, Clemens EB, Koutsakos M, Valkenburg SA, Gras S, Lappas M, Jaworowski A, Crowe J, Loh L, Kedzierska K
  J Leuk Biol. 2018 Feb; 103(2):321-339
• Glut1 expression level on inflammatory monocytes is associated with markers of cardiovascular disease risk in HIV-infected individuals.
  Anzinger JJ, Butterfield TR, Gouillou M, McCune JM, Crowe SM, Palmer CS
  J Acquir Immune Defic Syndr. 2018 Feb; 77(2):e28-e30
• People Born In Non-Main English Speaking Countries Are Less Likely To Start Hiv Treatment Early In Australia: A National Cohort Analysis, 2014-15.
  Gunaratnam P, McManus H, Watchirs-Smith L, McGregor S, Callander D, Brown G, Lobo R, O'Connor CC, Hellard M, Medland N, Lewis D, Palmer C, Law M, Gray R, Donovan B, Guy R; ACCESS Steering Committee
  J Acquir Immune Defic Syndr. 2018 Feb; 77(3):e31-e34
• Achieving hepatitis C elimination in Europe - to treatment scale up and beyond.
  Hellard M, Scott N, Sacks Davis R, Pedrana A
  J Hepatol. 2018 Feb; 68(3):383-385
• Ex vivo expression of chemokine receptors on cells surrounding cutaneous nerves in patients with HIV-associated sensory neuropathy.
  Mountford J, Octaviana F, Estiasari R, Setiawan DD, Ariyanto I, Lee S, Gaff J, Chew C, Jackaman C, Kamerman P, Cherry C, Price P
  AIDS. 2018 Feb; 32(4):431-441
• Modelling the elimination of hepatitis C as a public health threat in Iceland: a goal attainable by 2020.
  Scott N, Ólafsson S, Gottfreðsson M, Tyrfingsson T, Rúnarsdóttir V, Hansdottir I, Benitez Hernandez U, Sigmundsdóttir G, Hellard M
  J Hepatol. 2018 Feb; 68(5):932-939
• Declining prevalence of undiagnosed HIV in Melbourne: results from community-based bio-behavioural studies of gay and bisexual men.
  Stoové M, Asselin J, Pedrana A, Lea T, Hellard M, Wilson D, Prestage G, de Wit J, Holt M
  Aust N Z J Public Health. 2018 Feb; 42(1):57-61

January, 2018 (18)

• Exploiting immune cell metabolic machinery for functional HIV cure and the prevention of inflammaging.
  Palmer CS, Palchaudhuri R, Albargy H, Abdel-Mohsen M, Crowe SM
  F1000Res. 2018 Jan; 7:125
• Involving men to improve maternal and newborn health: A systematic review of the effectiveness of interventions.
  Tokhi M, Comrie-Thomson L, Davis J, Portela A, Chersich M, Luchters S
  PLoS One. 2018 Jan; 13(1):e0191620
• What Behaviors Do Young Heterosexual Australians See in Pornography? A Cross-Sectional Study.
  Davis AC, Carrotte ER, Hellard ME, Lim MSC
  J Sex Res. 2018 Jan; 55(3):310-319
• The effect of female sex on hepatitis C incidence among people who inject drugs: results from the international multi-cohort InC3 Collaborative.
  Esmaeili A, Mirzazadeh A, Morris MD, Hajarizadeh B, Sacks HS, Maher L, Grebely J, Kim AY, Lauer G, Cox AL, Hellard M, Dietze P, Bruneau J, Shoukry NH, Dore GJ, Lloyd AR, Prins M, Page K; InC3 Collaborative.
  Clin Infect Dis. 2018 Jan; 66(1):20-28
• Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial.
  Grebely J, Dalgard O, Conway B, Cunningham EB, Bruggmann P, Hajarizadeh B, Amin J, Bruneau J, Hellard M, Litwin AH, Marks P, Quiene S, Siriragavan S, Applegate TL, Swan T, Byrne J, Lacalamita M, Dunlop A, Matthews GV, Powis J, Shaw D, Thurnheer MC, Weltman M, Kronborg I, Cooper C, Feld JJ, Fraser C, Dillon JF, Read P, Gane E, Dore GJ; SIMPLIFY Study Group
  Lancet Gastroenterol Hepatol. 2018 Jan; 3(3):153-161
• The potential of task shifting selected maternal interventions to auxiliary midwives in Myanmar: a mixed-method study.
  Than KK, Tin KN, La T, Thant KS, Myint T, Beeson JG, Luchters S, Morgan A
  BMC Public Health. 2018 Jan; 18(1):99
• Frailty in men living with HIV: a cross-sectional comparison of three frailty instruments.
  Yeoh HL, Cheng A, Palmer C, Crowe SM, Hoy JF
  Antivir Ther. 2018 Jan; 23(2):117-127
• Psychological factors associated with painful versus non-painful HIV-associated sensory neuropathy.
  Pillay P, Wadley AL, Cherry CL, Karstaedt AS, Kamerman PR
  AIDS Behav. 2018 Jan; 22(5):1584-1595
• Acceptability and HIV prevention benefits of a peer-based model of rapid point of care HIV testing for Australian gay, bisexual and other men who have sex with men.
  Leitinger D, Ryan KE, Brown G, Pedrana A, Wilkinson AL, Ryan C, Hellard M, Stoové M
  AIDS Behav. 2018 Jan; 22(1):178-189
• Syndromic management of sexually transmissible infections in resource-poor settings: a systematic review with meta-analysis of the abnormal vaginal discharge flowchart for Neisseria gonorrhoea and Chlamydia trachomatis.
  van Gemert C, Hellard M, Bradshaw CS, Fowkes FJI, Agius PA, Stoove M, Bennett CM
  Sex Health. 2018 Jan; 15(1):1-12
• Antibody-dependent cellular cytotoxicity (ADCC) responses to seasonal influenza vaccination in older adults.
  Vanderven HA, Jegaskanda S, Wines BD, Hogarth PM, Carmuglia S, Rockman S, Chung AW, Kent SJ
  J Infect Dis. 2018 Jan; 217(1):12-23
• Epidemiology of chronic hepatitis B virus in Ireland using routinely collected surveillance and administrative data, 2004-2014.
  van Gemert CE, Murphy N, Mitchell TA, Hellard ME, Thornton L
  Ir J Med Sci. 2018 Jan; 187(3):803-811
• Critical examination of evidence for the nutritional status of children in Papua New Guinea - a systematic review.
  McGlynn PJ, Renzaho AΜ, Pham MD, Toole M, Fisher J, Luchters S
  Asia Pac J Clin Nutr. 2018 Jan; 27(1):1-18
• Adaptive reprogramming of NK cells in X-linked lymphoproliferative syndrome.
  Opat S, Hearps A, Thia K, Yuen A, Rogers B, Chachage M, Moore G, Shortt J, Ryland G, Blombery P, Schwarer AP, Noori T, Trapani JA, Jaworowski A, Voskoboinik I
  Blood. 2018 Jan; 131(6): 699-702
• Understanding the Targeting and Uptake of HIV Testing Among Gay and Bisexual Men Attending Sexual Health Clinics.
  Jamil MS, McManus H, Callander D, Prestage G, Ali H, O'Connor CC, Chen M, McNulty AM, Knight V, Duck T, Keen P, Gray J, Medland N, Hellard M, Lewis DA, Grulich AE, Kaldor JM, Fairley CK, Donovan B, Guy RJ; ACCESS and NSW Partnership Project Steering Committees.
  AIDS Behav. 2018 Jan; 22(2):513-521
• Assessing individual-level needle and syringe coverage parameters and the measurement of coverage in Melbourne, Australia: methods and impacts.
  O'Keefe D, Scott N, Aitken C, Dietze P
  J Public Health. 2018 Jan; 40(3):e336-e342
• Eliminating hepatitis C virus as a public health threat among HIV-positive men who have sex with men: a multi-modelling approach to understand differences in sexual risk behaviour.
  Scott N, Stoové M, Wilson DP, Keiser O, El-Hayek C, Doyle J, Hellard M
  J Int AIDS Soc. 2018 Jan; 21(1):e25059
• The City of Johannesburg can end AIDS by 2030: modelling the impact of achieving the Fast-Track targets and what it will take to get there.
  Stuart RM, Fraser-Hurt N, Kerr CC, Mabusela E, Madi V, Mkhwanazi F, Pillay Y, Barron P, Muzah B, Matsebula T, Gorgens M, Wilson DP
  J Int AIDS Soc. 2018 Jan; 21(1):e25068